|
|
 |
|
Viewing report
|
|
|
|
Acute Respiratory Distress Syndrome, Second Edition
Informa Healthcare, Nov 2009, Pages: 476
The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS).
Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS.
Highlights include:
- the definition, epidemiology, pathology, and pathogenesis of ARDS
- complications such as transfusion-related injury, and endothelium and vascular dysfunction
- the long-term outcomes of ARDS
- host defense and infection
- the latest developments in ARDS therapy: glucocorticoid therapy, surfactant therapy, mechanical ventilation, and mesenchymal stem cells
- predictive factors: gene expression profiling and biomarkers, and chemokines and cytokines
- advances in management strategies: fluid management, non-pulmonary and non-sepsis management, and glucose control
Customers who bought this item also bought
Nitric Oxide - Therapeutics, Markets and Companies
The Respiratory Diagnostic Devices Market Outlook to 2016
Respiratory Infections
Global Respiratory Care Devices Market (2010 - 2015)
Problem Solving in Haematology
Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
Acute and Critical Care Medicine at a Glance
Chronic Pain: An Atlas of Investigation and Management
Artificial cells, cell engineering and therapy
Global Acute Coronary Syndrome Drug Pipeline Capsule - 2012
|
|
|
|
